Additional file 3 of Neoadjuvant metformin added to conventional chemotherapy synergizes anti-proliferative effects in ovarian cancer

Chi Ying F Huang (Contributor)
Jun-Hung Lin (Contributor)
Alexander Wu (Creator)
Pi Lin Sung (Contributor)
Mong Hong Lee (Contributor)
Sai Ching J. Yeung (Contributor)
Ping Chieh Chou (Contributor)
Kuo-Chang Wen (Creator)

Dataset

Description

Additional file 3: Figure S3. Metformin at a Clinically Relevant Dosage Inhibits Human Ovarian Cancer Growth. a Growth of human ovarian cancer cells (SKOV3) incubated f with micromolar concentrations of metformin (0.5 mM) for several days. *: p

Date made available	2020
Publisher	Figshare

DOI
10.6084/m9.figshare.12845528.v1

Access Dataset

Creative Commons Attribution 4.0 International

1 Article

Neoadjuvant metformin added to conventional chemotherapy synergizes anti-proliferative effects in ovarian cancer
Wen, K. C., Sung, P. L., Wu, A. T. H., Chou, P. C., Lin, J. H., Huang, C. Y. F., Yeung, S. C. J. & Lee, M. H., Aug 21 2020, In: Journal of Ovarian Research. 13, 1, p. 95 95.
Research output: Contribution to journal › Article › peer-review

Open Access
28 Link opens in a new tab Citations (Scopus)

Cite this

DataSetCite

Huang, C. F. (Contributor), Lin, J. (Contributor), Wu, A. T. H. (Creator), Sung, P. (Contributor), Lee, M. (Contributor), Yeung, S. J. (Contributor), Chou, P. (Contributor), Wen, K. (Creator) (2020). Additional file 3 of Neoadjuvant metformin added to conventional chemotherapy synergizes anti-proliferative effects in ovarian cancer. Figshare. 10.6084/m9.figshare.12845528.v1

Additional file 3 of Neoadjuvant metformin added to conventional chemotherapy synergizes anti-proliferative effects in ovarian cancer

Description

DOI

Access Dataset

Research output

Neoadjuvant metformin added to conventional chemotherapy synergizes anti-proliferative effects in ovarian cancer

Cite this